Loading...
Loading...
Of the 5 tracked institutions holding ORGN, 2 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +8.4pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 5 tracked institutional investors we monitor, ORGN (ORIGIN MATERIALS INC) is held with a combined value of $406.58K across 178,327 shares. The largest holder is RENAISSANCE TECHNOLOGIES LLC with a position worth $183.44K. 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$406.58K
Total Shares Held
178,327
Institutional Holders
5
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $183.44K | 0.00% | New |
| 2 | BlackRock, Inc. | $148.79K | 0.00% | New |
| 3 | STATE STREET CORP | $39.40K | 0.00% | New |
| 4 | CITADEL ADVISORS LLC | $29.77K | 0.00% | New |
| 5 | FMR LLC | $5.19K | 0.00% | New |
As of the latest SEC 13F filings, RENAISSANCE TECHNOLOGIES LLC is the largest institutional holder of ORGN with a position worth $183.44K, representing 0.00% of their portfolio. In total, 5 institutional investors hold ORGN with a combined value of $406.58K.
In the most recent quarter, 5 funds opened a new position in ORGN.
Institutional investors hold $406.58K worth of ORGN stock across 5 positions. The largest institutional holder is RENAISSANCE TECHNOLOGIES LLC with $183.44K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ORGN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ORGN positions.
None this quarter.
